Selected research
Industry Research
Drug Stability Testing Services Industry Research Report 2026
Market perspective
The global Drug Stability Testing Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug Stability Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Stability Testing Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Stability Testing Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Stability Testing Services include SGS, Nelson Labs, Q Laboratories, Auriga Research, Intertek, Catalent, Pace Analytical, Charles River Laboratories and Impact Analytical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Drug Stability Testing Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Stability Testing Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Stability Testing Services Market by Company
SGS
Nelson Labs
Q Laboratories
Auriga Research
Intertek
Catalent
Pace Analytical
Charles River Laboratories
Impact Analytical
Prolytix
Almac
Galbraith Laboratories, Inc.
Element
Drug Stability Testing Services Segment by Type
Early Development Stability Testing Services
Clinical Stability Testing Services
Predictive Stability Testing Services
In-use Stability Testing Services
Others
Drug Stability Testing Services Segment by Application
Pharmaceuticals
Biologics
Others
Drug Stability Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Stability Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Stability Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Stability Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Stability Testing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Early Development Stability Testing Services
- Clinical Stability Testing Services
- Predictive Stability Testing Services
- In-use Stability Testing Services
- Others
Applications
- Pharmaceuticals
- Biologics
- Others
Companies covered
- SGS
- Nelson Labs
- Q Laboratories
- Auriga Research
- Intertek
- Catalent
- Pace Analytical
- Charles River Laboratories
- Impact Analytical
- Prolytix
- Almac
- Galbraith Laboratories, Inc.
- Element
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Stability Testing Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Early Development Stability Testing Services
- 2.2.3 Clinical Stability Testing Services
- 2.2.4 Predictive Stability Testing Services
- 2.2.5 In-use Stability Testing Services
- 2.2.6 Others
- 2.3 Drug Stability Testing Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceuticals
- 2.3.3 Biologics
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Drug Stability Testing Services Breakdown Data by Type
- 3.1 Global Drug Stability Testing Services Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Stability Testing Services Forecasted Market Size by Type (2027-2032)
4 Drug Stability Testing Services Breakdown Data by Application
- 4.1 Global Drug Stability Testing Services Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Stability Testing Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Stability Testing Services Market Perspective (2021-2032)
- 5.2 Global Drug Stability Testing Services Growth Trends by Region
- 5.2.1 Global Drug Stability Testing Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Stability Testing Services Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Stability Testing Services Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Stability Testing Services Market Dynamics
- 5.3.1 Drug Stability Testing Services Industry Trends
- 5.3.2 Drug Stability Testing Services Market Drivers
- 5.3.3 Drug Stability Testing Services Market Challenges
- 5.3.4 Drug Stability Testing Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Stability Testing Services Players by Revenue
- 6.1.1 Global Top Drug Stability Testing Services Players by Revenue (2021-2026)
- 6.1.2 Global Drug Stability Testing Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Stability Testing Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Stability Testing Services Head Office and Area Served
- 6.4 Global Drug Stability Testing Services Players, Product Type & Application
- 6.5 Global Drug Stability Testing Services Manufacturers Established Date
- 6.6 Global Drug Stability Testing Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Stability Testing Services Market Size (2021-2032)
- 7.2 North America Drug Stability Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Stability Testing Services Market Size by Country (2021-2026)
- 7.4 North America Drug Stability Testing Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Stability Testing Services Market Size (2021-2032)
- 8.2 Europe Drug Stability Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Stability Testing Services Market Size by Country (2021-2026)
- 8.4 Europe Drug Stability Testing Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Stability Testing Services Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Stability Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Stability Testing Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Stability Testing Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Stability Testing Services Market Size (2021-2032)
- 10.2 South America Drug Stability Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Stability Testing Services Market Size by Country (2021-2026)
- 10.4 South America Drug Stability Testing Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Stability Testing Services Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Stability Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Stability Testing Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Stability Testing Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 SGS
- 12.1.1 SGS Company Information
- 12.1.2 SGS Business Overview
- 12.1.3 SGS Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.1.4 SGS Drug Stability Testing Services Product Portfolio
- 12.1.5 SGS Recent Developments
- 12.2 Nelson Labs
- 12.2.1 Nelson Labs Company Information
- 12.2.2 Nelson Labs Business Overview
- 12.2.3 Nelson Labs Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.2.4 Nelson Labs Drug Stability Testing Services Product Portfolio
- 12.2.5 Nelson Labs Recent Developments
- 12.3 Q Laboratories
- 12.3.1 Q Laboratories Company Information
- 12.3.2 Q Laboratories Business Overview
- 12.3.3 Q Laboratories Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.3.4 Q Laboratories Drug Stability Testing Services Product Portfolio
- 12.3.5 Q Laboratories Recent Developments
- 12.4 Auriga Research
- 12.4.1 Auriga Research Company Information
- 12.4.2 Auriga Research Business Overview
- 12.4.3 Auriga Research Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.4.4 Auriga Research Drug Stability Testing Services Product Portfolio
- 12.4.5 Auriga Research Recent Developments
- 12.5 Intertek
- 12.5.1 Intertek Company Information
- 12.5.2 Intertek Business Overview
- 12.5.3 Intertek Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.5.4 Intertek Drug Stability Testing Services Product Portfolio
- 12.5.5 Intertek Recent Developments
- 12.6 Catalent
- 12.6.1 Catalent Company Information
- 12.6.2 Catalent Business Overview
- 12.6.3 Catalent Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.6.4 Catalent Drug Stability Testing Services Product Portfolio
- 12.6.5 Catalent Recent Developments
- 12.7 Pace Analytical
- 12.7.1 Pace Analytical Company Information
- 12.7.2 Pace Analytical Business Overview
- 12.7.3 Pace Analytical Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.7.4 Pace Analytical Drug Stability Testing Services Product Portfolio
- 12.7.5 Pace Analytical Recent Developments
- 12.8 Charles River Laboratories
- 12.8.1 Charles River Laboratories Company Information
- 12.8.2 Charles River Laboratories Business Overview
- 12.8.3 Charles River Laboratories Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.8.4 Charles River Laboratories Drug Stability Testing Services Product Portfolio
- 12.8.5 Charles River Laboratories Recent Developments
- 12.9 Impact Analytical
- 12.9.1 Impact Analytical Company Information
- 12.9.2 Impact Analytical Business Overview
- 12.9.3 Impact Analytical Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.9.4 Impact Analytical Drug Stability Testing Services Product Portfolio
- 12.9.5 Impact Analytical Recent Developments
- 12.10 Prolytix
- 12.10.1 Prolytix Company Information
- 12.10.2 Prolytix Business Overview
- 12.10.3 Prolytix Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.10.4 Prolytix Drug Stability Testing Services Product Portfolio
- 12.10.5 Prolytix Recent Developments
- 12.11 Almac
- 12.11.1 Almac Company Information
- 12.11.2 Almac Business Overview
- 12.11.3 Almac Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.11.4 Almac Drug Stability Testing Services Product Portfolio
- 12.11.5 Almac Recent Developments
- 12.12 Galbraith Laboratories, Inc.
- 12.12.1 Galbraith Laboratories, Inc. Company Information
- 12.12.2 Galbraith Laboratories, Inc. Business Overview
- 12.12.3 Galbraith Laboratories, Inc. Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.12.4 Galbraith Laboratories, Inc. Drug Stability Testing Services Product Portfolio
- 12.12.5 Galbraith Laboratories, Inc. Recent Developments
- 12.13 Element
- 12.13.1 Element Company Information
- 12.13.2 Element Business Overview
- 12.13.3 Element Revenue in Drug Stability Testing Services Business (2021-2026)
- 12.13.4 Element Drug Stability Testing Services Product Portfolio
- 12.13.5 Element Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst